Conceive Your Family What are GLP-1 medications such as Wegovy & Zepbound
This underscores the need for thoughtful discontinuation strategies tailored to the patient, which can be challenging without clear guidelines or guidance from robust research studies
Even modest increases in activity such as 30 minutes of brisk walking five days a week can meaningfully enhance weight loss outcomes
It is known that the CV protection effect of GLP-1RAs have been proven through eight large-scale clinical studies, including Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) [66], LEADER [44], Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN)-6 [67], Exenatide Study of Cardiovascular Event Lowering (EXSCEL) [68], Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes) [69], Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) [70], Peptide Innovation for Early Diabetes Treatment (PIONEER) 6 [67,71], and AMPLITUDE-O [51]
It is usually mild to moderate and improves with continued use
Why is the survodutide trial important
